Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study von Bakouny, Z, Labaki, C, Bhalla, S, Schmidt, A L, Steinharter, J A, Cocco, J, Tremblay, D A, Awad, M M, Kessler, A, Haddad, R I, Evans, M, Busser, F, Wotman, M, Curran, C R, Zimmerman, B S, Bouchard, G, Jun, T, Nuzzo, P V, Qin, Q, Hirsch, L, Feld, J, Kelleher, K M, Seidman, D, Huang, H, Anderson-Keightly, H M, El Zarif, T, Alaiwi, S Abou, Champagne, C, Rosenbloom, T D, Stewart, P S, Johnson, B E, Trinh, Q, Tolaney, S M, Galsky, M D, Choueiri, T K, Doroshow, D B

Volltext

LBA74 Disparities in cancer during the COVID-19 pandemic: COVID-19 and cancer outcomes study (CCOS) von Doroshow, D., Schmidt, A.L., Bakouny, Z., Bhalla, S., Steinharter, J.A., Tremblay, D., Awad, M.M., Kessler, A.J., Bouchard, G., Evans, M., Busser, F., Zimmerman, B.S., Curran, C.R., Jun, T., Haddad, R., Qin, Q., Nuzzo, P.V., Feld, J., Galsky, M.D., Choueiri, T.K.

Volltext

Activity of cabozantinib (cabo) after PD-1/PD-L1 immune checkpoint blockade (ICB) in metastatic clear cell renal cell carcinoma (mccRCC) von McGregor, B.A., Lalani, A.-K., Xie, W., Steinharter, J.A., Martini, D.J., Nuzzo, P.V., Martinez Chanza, N., Harshman, L.C., Bilen, M.A., Choueiri, T.K.

Volltext

Change in neutrophil-to-lymphocyte ratio (NLR) in response to immunotherapy for metastatic renal cell carcinoma (mRCC) von Lalani, A-K.A., Xie, W., Martini, D.J., Norton, C.K., Steinharter, J.A., Bossé, D., Bellmunt, J., Van Allen, E.M., McGregor, B.A., Harshman, L.C., Choueiri, T.K.

Volltext

Efficacy of immune checkpoint inhibitors (ICI) and genomic alterations by body mass index (BMI) in advanced renal cell carcinoma (RCC) von Lalani, A-K A, Bakouny, Z., Farah, S., Xie, W., Flippot, R., Steinharter, J.A., Nuzzo, P.V., Fleischer, J., Pal, S.K., Rathi, N., Hansen, A.R., Donskov, F., Dudani, S., Yuasa, T., Vaishampayan, U., Subasri, M., Wells, J.C., Basappa, N.S., Heng, D.Y.C., Choueiri, T.K.

Volltext

976P - Efficacy of immune checkpoint inhibitors (ICI) and genomic alterations by body mass index (BMI) in advanced renal cell carcinoma (RCC) von Lalani, A-K A, Bakouny, Z., Farah, S., Xie, W., Flippot, R., Steinharter, J.A., Nuzzo, P.V., Fleischer, J., Pal, S.K., Rathi, N., Hansen, A.R., Donskov, F., Dudani, S., Yuasa, T., Vaishampayan, U., Subasri, M., Wells, J.C., Basappa, N.S., Heng, D.Y.C., Choueiri, T.K.

Volltext